Publication|Articles|May 1, 2003

May 2003
Volume 9
Issue 5

Effect of Off-Label Use of Oncology Drugs on Pharmaceutical Costs: The Rituximab Experience

Author(s)Darren Kocs, MD, MHSA, A. Mark Fendrick, MD

Download PDF: Effect of Off-Label Use of Oncology Drugs on Pharmaceutical Costs: The Rituximab Experience

Articles in this issue

about 23 years ago

Article

Lansoprazole Overutilization: Methods for Step-Down Therapy

about 23 years ago

Article

Reducing Costs and Improving Outcomes of Percutaneous Coronary Interventions

about 23 years ago

Article

Evaluation of a Depression Health Management Program to Improve Outcomes in First or Recurrent Episode Depression

about 23 years ago

Article

A Prediction Model for Targeting Low-Cost, High-Risk Members of Managed Care Organizations

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Blood Pressure Control Among Adherent vs Nonadherent Medicare Patients With Hypertension

ByKaitlyn T. Haas, PharmD,Joseph J. Saseen, PharmD, BCPS, BCACP,Oliver Titus, MS,Nathan Lamberton, PharmD, BCACP,Lisa M. Schilling, MD, MSPH,Keri N. Hogan, PharmD, BCACP,Alison Marks, BA,Sarah J. Billups, PharmD, BCPS

July 1st 2026

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

ByOnur Baser, PhD, MS,Heidi C. Waters, PhD,Nehir Yapar, BS,Gabriela Samayoa, MD, MPH,Xue Han, PhD,Deborah Freedman, MBA,Lauren Isenman, MPH,Rashmi Patel, MD, PhD

June 12th 2026

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

ByJason Bartock, MD,Adam Green, MD,Raquel Nahra, MD,Amy Bordogna, MD,Amir Davoodi, MD,Jean-Sebastien Rachoin, MD

June 11th 2026

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

ByDana R. Fletcher, PhD,Lisa M. Sandy, MA,Joy Waughtal, MPH,Cole Hoffman, MS,Sylvie Novins-Montague, BA,Patrick Hosokawa, MS,Pamela N. Peterson, MD, MSPH,Larry A. Allen, MD, MPH,Sheana Bull, PhD,P. Michael Ho, MD, PhD

June 10th 2026

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

ByRazanne Oueini, PharmD,Ben Shirley, BS,Christie Teigland, PhD,Melissa Castora-Binkley, PhD, MA,Scott Bilder, PhD,Kiran Sunkari, MS,Lynn Pezzullo, RPh

Effect of Off-Label Use of Oncology Drugs on Pharmaceutical Costs: The Rituximab Experience

Articles in this issue

Related Content

Blood Pressure Control Among Adherent vs Nonadherent Medicare Patients With Hypertension

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

Trending on AJMC

Ocrelizumab Led to Declines in Immunoglobulins in Patients With MS

Orca-T Gains FDA Approval for Matched Donor Stem Cell Transplant

Racial Gaps in Cancer Pain Management Persist in Community Care: Ila Sruti, MPH

House Panel Advances Bills to Expand Veterans’ Health Care Access

NCCN Adds Pemivibart for COVID-19 Prevention in B-Cell Lymphomas

Access, Affordability, & Accountability: A New Era in Oncology Reimbursement

Effect of Off-Label Use of Oncology Drugs on Pharmaceutical Costs: The Rituximab Experience

Articles in this issue

Related Content

Blood Pressure Control Among Adherent vs Nonadherent Medicare Patients With Hypertension

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

Trending on AJMC

Ocrelizumab Led to Declines in Immunoglobulins in Patients With MS

Orca-T Gains FDA Approval for Matched Donor Stem Cell Transplant

Racial Gaps in Cancer Pain Management Persist in Community Care: Ila Sruti, MPH

House Panel Advances Bills to Expand Veterans’ Health Care Access

NCCN Adds Pemivibart for COVID-19 Prevention in B-Cell Lymphomas